COMMUNIQUÉS West-GlobeNewswire

IntelGenx to Report First Quarter 2019 Financial Results on May 9, 2019 – Conference Call to Follow
02/05/2019
SAINT LAURENT, Quebec, May 02, 2019 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) today announced that it will release its first quarter 2019 financial results after market close on May [...]
MyoKardia to Report First Quarter 2019 Financial Results on Thursday, May 9, 2019
02/05/2019
SOUTH SAN FRANCISCO, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of serious [...]
CytomX Therapeutics to Announce First Quarter 2019 Financial Results
02/05/2019
-Teleconference Scheduled for May 9, 2019, at 5:00 p.m. ET- SOUTH SAN FRANCISCO, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical [...]
Homology Medicines Presents Data from Gene Therapy and Gene Editing Programs and Manufacturing Capabilities at ASGCT Meeting
02/05/2019
- Homology’s Scalable HEK293 Suspension Manufacturing Process for AAVHSCs Demonstrated Superiority to a Baculovirus System and AAVHSC15 Showed Improved In Vivo Efficacy Compared to AAV5 in PKU Model - - Non-clinical [...]
CareDx Adds iBox Technology, Next Step Towards Artificial Intelligence in Transplant Care
02/05/2019
CareDx collaboration with Cibiltech provides prognostic information on allograft survival BRISBANE, Calif., May 02, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the [...]
Immunomedics to Report First Quarter 2019 Results and Host Conference Call and Webcast on May 9, 2019
02/05/2019
MORRIS PLAINS, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
Samumed Launches Phase 3 Lorecivivint (SM04690) Clinical Program in Knee Osteoarthritis
02/05/2019
Pivotal STRIDES trials to be conducted to support lorecivivint as a potential disease-modifying treatment for knee osteoarthritis First patient dosing is anticipated in the second quarter of 2019 SAN DIEGO, May 02, 2019 [...]
PhaseBio To Report First Quarter 2019 Financial Results and Recent Corporate Progress on May 9, 2019
02/05/2019
MALVERN, Pa. and SAN DIEGO, May 02, 2019 (GLOBE NEWSWIRE) -- PhaseBio Pharmaceuticals, Inc. (Nasdaq: PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies [...]
Chipmunk Health chooses Philips HealthSuite digital platform to roll out and scale up its telehealth services
02/05/2019
May 1, 2019 Powered by Philips’ HealthSuite digital platform, new General Practitioner telehealth service from Chipmunk Health aims to forge a closer and more effective relationship between patients and their doctors [...]
Release date of three-month interim report 2019 for ALK and audio cast
02/05/2019
On Thursday, 9 May 2019, ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) releases its three-month interim report 2019. ALK will host a meeting for analysts and institutional investors that day at 13.30 p.m. (CEST) at which [...]
So-Young Announces Pricing of Initial Public Offering
02/05/2019
BEIJING, May 02, 2019 (GLOBE NEWSWIRE) -- So-Young International Inc. (NASDAQ: SY) (“So-Young” or the “Company”), the most popular online destination for discovering, evaluating and reserving medical aesthetic services [...]
LIDDS develops its own proprietary product for intratumoral immunotherapy - Freedom to operate analysis done for the TLR9-agonist project
02/05/2019
LIDDS has an ongoing preclinical development program based on a clinical stage TLR9 agonist. The objective is to use a NanoZolid® formulation with the TLR9 agonist as an intratumoral immunotherapy in combination with [...]
First patient treated with C-RAD’s cutting-edge positioning system at the Cancer Care Center Negrar-Verona, Italy
02/05/2019
C-RAD and Ospedale Sacro Cuore Don Calabria – the Cancer Care Center in Negrar-Verona - announced today that the first patient has been treated with C-RAD’s surface tracking system at the site. In Italy, the [...]
Statement re Cancellation
02/05/2019
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION Certain information contained [...]
Biocartis Group NV: BIOCARTIS LAUNCHES CONVERTIBLE BONDS OFFERING OF EUR 125 MILLION
02/05/2019
PRESS RELEASE : REGULATED INFORMATION - INSIDE INFORMATION 2 May 2019, 08:00 CEST BIOCARTIS LAUNCHES CONVERTIBLE BONDS OFFERING OF EUR 125 MILLION Mechelen, Belgium, 2 May 2019 - Biocartis Group NV ("Biocartis" or the " [...]
MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2018
02/05/2019
MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2018 Paris, le 2 mai 2019 – 8h00 Eurobio Scientific (FR0013240934, ALERS, éligible PEA-PME), groupe français leader dans le diagnostic médical in vitro de spécialité, [...]
AroCell expands its distribution network and signs distribution agreement with Inveniolife
02/05/2019
AroCell AB (publ) announce today that a distribution agreement has been signed with the Mumbai based company Inveniolife Technology Pvt. Ltd. for the promotion and distribution of the AroCell TK 210™ ELISA in India. [...]
DBV Technologies to Attend Upcoming Investor Conferences
02/05/2019
Montrouge, France, May 2, 2019 DBV Technologies to Attend Upcoming Investor Conferences DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, [...]
DBV Technologies invitée à présenter lors de prochaines conférences Investisseurs
02/05/2019
Montrouge, France, le 2 mai (7H30 CET), 2019 DBV Technologies invitée à présenter lors de prochaines conférences Investisseurs DBV Technologies (Euronext: DBV – ISIN : FR0010417345 - Nasdaq Stock Market : DBVT), une [...]

Pages